Aspirin use for primary prevention among US adults with and without elevated Lipoprotein(a)

By sjmartinez • May 14, 2024

Razavi AC, Richardson LC, Coronado F, Dzaye O, Bhatia HS, Mehta A, Quyyumi AA, Vaccarino V, Budoff MJ, Nasir K, Tsimikas S, Whelton SP, Blaha MJ, Blumenthal RS, Sperling LS. Aspirin use for primary prevention among US adults with and without elevated Lipoprotein(a). Am J Prev Cardiol. 2024 Apr 27;18:100674. doi: 10.1016/j.ajpc.2024.100674. PMID: 38741703; PMCID: PMC11090055.

Tags: Aspirin, Cardiology/Epi, cardiovascular disease, Harbor UCLA, lipoprotein(a), NHANES, Publications

The noncanonical NFκB pathway: Regulatory mechanisms in health and disease

Rodriguez BN, Huang H, Chia JJ, Hoffmann A. The noncanonical NFκB pathway: Regulatory mechanisms in health and disease. WIREs Mech Dis. 2024 Nov-Dec;16(6):e1646. doi: 10.1002/wsbm.1646.[...]

Acute Coronary Syndrome in Women

Cader FA, Sareen N, Press MC. Acute Coronary Syndrome in Women. Interv Cardiol Clin. 2025 Jan;14(1):9-19. doi: 10.1016/j.iccl.2024.08.011. PMID: 39537292.

The Rebirth of Intraoperative Electrophysiological Mapping for Complex Congenital Heart Disease

Moore JP, Shivkumar K. The Rebirth of Intraoperative Electrophysiological Mapping for Complex Congenital Heart Disease. J Am Coll Cardiol. 2024 Nov 19;84(21):2113-2115. doi: 10.1016/j.jacc.2024.08.078. PMID:[...]